SCHEMBL28690280

SCHEMBL28690280

O=Cc1ccc(N2CCN(c3cnccn3)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ TRIM24 O15164 1/20 0.53
▸ TRIM33 Q9UPN9 1/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ GPR119 Q8TDV5 1/20 0.52
▸ KDM4E B2RXH2 6/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ SORD Q00796 1/20 0.46
▸ LMNA P02545 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ SLC6A7 Q99884 1/20 0.44
▸ METAP1 P53582 1/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28710385 0.79 ALDH1A1 (0.47) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL7958672 0.79 TRIM24 (0.66) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL28704014 0.78 TRIM24 (0.56) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL2561698 0.78 TRIM24 (0.83) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL3077544 0.78 TRIM24 (0.83) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL7678393 0.76 L3MBTL1 (0.50) ALDH1A1GPR119KDM4ESORDLMNA
SCHEMBL7660354 0.74 MAPT (0.62) TRIM24TRIM33ALDH1A1GPR119KDM4E
SCHEMBL6183959 0.72 SORD (0.51) KDM4ESORDLMNAL3MBTL1HRH3
SCHEMBL1914424 0.72 MAPT (0.48) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2
SCHEMBL20644619 0.72 ALDH1A1 (0.47) TRIM24TRIM33ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109563092-B 2-phenylimidazo [4,5-B ] pyridin-7-amine derivatives useful as inhibitors of the activity of the mammalian tyrosine kinase ROR1 坎塞拉有限公司 2021-09-14 — — CN disclosed
Send feedback